Health Mar 16 White House warns U.S. could be ‘blindsided’ by the next variant without more COVID funding from Congress The White House is begging Congress for more funds to help with COVID-19 surveillance, testing, and treatments — a call that could be bolstered by emerging signs of an increase in COVID-19 cases in Europe.
Health Dec 28 3 questions scientists are working to answer about the new coronavirus variant When a new viral variant emerges, experts want to know how well it spreads, whether it changes the disease, and whether it affects immunity.
Health Oct 05 Trump is receiving a steroid usually given to patients with severe COVID-19 The announcement from Trump’s medical team Sunday morning that the president is on dexamethasone is sure to increase speculation about the president’s illness and was at odds with the generally upbeat description of his condition provided by his physicians.
Science Jan 06 A deep dive into newborns’ DNA may reveal potential disease risks — but is the testing worth it? Looking for diseases in newborns’ DNA that could arise during adulthood is more ethically fraught than focusing on childhood conditions.
Science Dec 15 Purdue’s secret OxyContin papers should be released, appeals court rules A Kentucky appeals court sided with STAT, upholding a ruling ordering the release of Purdue Pharma records about the marketing of the opioid OxyContin.
Science Oct 14 Rewriting reproduction: With stem cells and CRISPR, scientists breed mice with same-sex parents For the first time, scientists said Thursday that they had bred mice with two genetic fathers.
Health Sep 13 Seven U.S. states now have adult obesity rates of 35 percent or higher Seven U.S. states now have adult obesity rates of 35 percent or higher, up from zero states just five years ago, according to federal data.
Health Jun 16 Controversial NIH study of ‘moderate drinking’ will be terminated after scathing report The National Institutes of Health will shut down a controversial industry-funded study of moderate drinking and heart disease after a task force found severe ethical and scientific lapses in the study’s planning and execution, the agency’s director said Friday.
Health Jan 14 At $850,000, price for new childhood blindness gene therapy four times too high, analysis says Luxturna, a gene therapy with a list price $850,000, is the latest flashpoint in the debate over how to afford innovative medicines.
Health Aug 10 These states declared an emergency over the opioid crisis. Here’s what happened Most national emergency declarations, which grant the government temporary new powers with little in the way of oversight, have come in response to natural disasters or the spread of infectious diseases like the H1N1 virus. They allow the federal government…